Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

STRATA Skin Sciences Inc

SSKN
Current price
2.57 USD -0.032 USD (-1.23%)
Last closed 2.68 USD
ISIN US86272A2069
Sector Healthcare
Industry Medical Devices
Exchange NASDAQ
Capitalization 12 475 939 USD
Yield for 12 month -47.55 %
1Y
3Y
5Y
10Y
15Y
SSKN
21.11.2021 - 28.11.2021

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania. Address: 5 Walnut Grove Drive, Horsham, PA, United States, 19044

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

16.00 USD

P/E ratio

Dividend Yield

Current Year

+33 357 999 USD

Last Year

+36 161 000 USD

Current Quarter

+8 797 000 USD

Last Quarter

+8 435 000 USD

Current Year

+18 460 999 USD

Last Year

+21 768 000 USD

Current Quarter

+5 307 000 USD

Last Quarter

+4 937 000 USD

Key Figures SSKN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 80 000 USD
Operating Margin TTM -5.76 %
Price to Earnings
Return On Assets TTM -6.79 %
PEG Ratio -0.020
Return On Equity TTM -62.97 %
Wall Street Target Price 16.00 USD
Revenue TTM 32 730 000 USD
Book Value 3.62 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 2.20 %
Dividend Yield
Gross Profit TTM 19 850 000 USD
Earnings per share -2.60 USD
Diluted Eps TTM -2.60 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -25.40 %

Dividend Analytics SSKN

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History SSKN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:10
Payout Ratio
Last Split Date 07.06.2024

Stock Valuation SSKN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.67
Price Sales TTM 0.38
Enterprise Value EBITDA -7 008.83
Price Book MRQ 1.34

Financials SSKN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators SSKN

For 52 weeks

2.51 USD 6.45 USD
50 Day MA 3.01 USD
Shares Short Prior Month 6 997
200 Day MA 3.57 USD
Short Ratio 0.44
Shares Short 5 752
Short Percent 0.22 %
Dividend information is being updated